Skip to content

Clinical observation of 595nm dye laser in the treatment of rosacea using different sizes of light spot

Clinical observation of 595nm dye laser in the treatment of rosacea using different sizes of light spot

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042816
Enrollment
Unknown
Registered
2021-01-28
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Group 1:PDL595 nm with 10 mm spot
Group 2: PDL595 nm with 7 mm spot

Sponsors

Yunnan Traditional Chinese medicine hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Aged from 20 to 55 years old, male or female, without definite systemic organic diseases; (2) According to the diagnostic criteria of capillary rosacea ; (3) One month before the study, the subjects did not receive other treatment methods (such as drugs affecting vasomotor function, chemical exfoliation, other laser therapy, etc.); (4) During the study period, no other vascular treatment of laser and external therapy were used; (5) Informed consent has been signed and willing to complete the research process.

Exclusion criteria

Exclusion criteria: (1) Patients with serious medical diseases such as heart disease, hypertension and scar constitution; (2) Pregnant, expectant or lactating women; (3) A long history of alcohol and drug abuse; (4) Have mental retardation or mental disorder; (5) Facial herpes simplex or ulceration, immersion, erosion and other skin lesions; (6) During the whole study period, we can not guarantee that we will not accept other treatment methods (such as drugs, laser, etc.); (7) Staff directly involved in the study; (8) Patients who are currently participating in other clinical studies or have participated in other clinical studies within 3 months; (9) According to the judgment of the researcher, the compliance of any aspect of the protocol (including visit plan and completion of diary card or questionnaire) may be affected due to frequent changes in the body, educational level or working environment of the subjects.

Design outcomes

Primary

MeasureTime frame
Erythema value;

Countries

China

Contacts

Public ContactDi Wu

Yunnan Traditional Chinese Medicine Hospital

66314655@qq.com+86 13888268353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026